跳至主要内容
临床试验/NCT01453660
NCT01453660进行中(未招募)不适用

A Pilot Study Measuring Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2011年10月11日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
44
试验地点
1
主要终点
Measure the endothelial reactivity (PAT-RH) in both groups

研究概览

简要总结

Cisplatin is one of the most common chemotherapy drugs used to treat many different cancers, including germ cell tumors (GCT). Cisplatin is very effective in treating GCT, but there are side effects. One of the possible long-term side effects of cisplatin is thought to be heart disease. The way that cisplatin causes heart disease is not well understood. One possibility is that cisplatin may damage the inside layer of blood vessels called the endothelium. The purpose of this study is to measure changes in the endothelium that happen when patients with GCT get cisplatin chemotherapy and to compare these changes with a group of patients not receiving chemotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Cisplatin-Based Chemotherapy Group
  • •Histologically-proven diagnosis of GCT
  • •No prior exposure to chemotherapy or radiation
  • •Planned to receive 3-4 cycles of cisplatin-based chemotherapy
  • •Surgery-Only Group
  • •Histologically-proven diagnosis of GCT Male
  • •Surgical management of GCT performed less than 90 days before start of study (includes orchiectomy and primary retroperitoneal lymph node dissection (RPLND))
  • •No prior exposure to chemotherapy or radiation

排除标准

  • •Cisplatin-Based Chemotherapy Group
  • •Prior exposure to chemotherapy or radiation
  • •Known diagnosis or history of being diagnosed with vasculitis, autonomic dysfunction, coronary artery disease, or collagen-vascular disease
  • •Surgery-Only Group
  • •Prior exposure to chemotherapy or radiation
  • •Planned for non-surgical management with chemotherapy or radiation.
  • •Known diagnosis or history of being diagnosed with vasculitis, autonomic dysfunction, coronary artery disease, or collagen-vascular disease.

结局指标

主要结局

Measure the endothelial reactivity (PAT-RH) in both groups

时间窗: 15 minutes

The Endo-PAT quantifies the endothelium-mediated changes in vascular tone, elicited by a 5-minute occlusion of the brachial artery (using a standard BP cuff).

次要结局

  • Identify sociodemographic(2 years)
  • Identify comorbid health conditions(2 years)
  • Measure PAT-RH index(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验